SCHEMBL24519738

SCHEMBL24519738

CNn1nccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23758072 0.50
SCHEMBL75323 0.48
SCHEMBL22091 0.48
Iodide SCHEMBL11779085 0.44
Dimethylamine SCHEMBL9751033 0.44
Hydrochloric Acid SCHEMBL8529934 0.44 KDM4E (1.00)
Hydrochloric Acid SCHEMBL743762 0.44
Dimethylamine SCHEMBL11209941 0.44
Dimethylamine SCHEMBL19253874 0.44
Hydrochloric Acid SCHEMBL9118581 0.44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-10-05 US disclosed
US-11572364-B2 Pteridinone compounds and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-02-07 US disclosed
EP-3519411-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2022-06-22 EP disclosed